Marathon profit beats estimates on soaring margins; strikes $4.2 billion refinery deal with CVR - Reuters

Marathon profit beats estimates on soaring margins; strikes $4.2 billion refinery deal with CVR - Reuters
Hologic says 2026 CVR is more challenging with stopped shipment of product
23andMe gains after CEO Wojcicki makes revised $2.94/share offer with CVR
Icahn Enterprises’ stock slides 4% as majority-owned CVR Energy suspends its dividend
QSAM to be acquired by Telix for $33.1M plus $90M CVR
Icosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, Canada
10.92MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
AMEX
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1680881026
CUSIP
168088102
Sector
Industrials
Industry
Tools & Accessories
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
2.46
Book Value
18.07
Dividend Share
0.09
Dividend Yield
0.80%
Earnings Share
-2.53
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
27,434,688
Gross Profit TTM
3,014,850
EBITDA
-1,425,177
Profit Margin
-8.90%
Return On Assets TTM
-6.89%
Return On Equity TTM
-13.04%
Revenue Per Share TTM
28.396
Qtly Revenue Growth YOY
-0.80%
Diluted Eps TTM
-2.53
Qtly Earnings Growth YOY
1972.90%
Trailing PE
0.00
Forward PE
14
Price Sales TTM
0.3627
Price Book MRQ
0.6255
Enterprise Value Revenue
0
Enterprise Value EBITDA
10
496.04
5.02%17.64
4.11%86.08
0.84%28.57
0.00%27.91
-2.04%104.62
-1.90%107.26
-1.58%362.04
-1.05%284.55
-0.71%33.50
-0.03%